Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice.

Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB.

J Leukoc Biol. 2008 Oct;84(4):1213-21. doi: 10.1189/jlb.0408231. Epub 2008 Jul 24.

PMID:
18653784
2.

The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice.

Manjavachi MN, Quintão NL, Campos MM, Deschamps IK, Yunes RA, Nunes RJ, Leal PC, Calixto JB.

Eur J Pain. 2010 Jan;14(1):23-31. doi: 10.1016/j.ejpain.2009.01.007. Epub 2009 Mar 4.

PMID:
19264522
3.

CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.

Braber S, Overbeek SA, Koelink PJ, Henricks PA, Zaman GJ, Garssen J, Kraneveld AD, Folkerts G.

Eur J Pharmacol. 2011 Oct 15;668(3):443-9. doi: 10.1016/j.ejphar.2011.03.025. Epub 2011 Mar 31.

PMID:
21458445
4.

Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.

Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB.

Br J Pharmacol. 2009 Jul;157(6):1034-44. doi: 10.1111/j.1476-5381.2009.00271.x. Epub 2009 Jun 5.

5.

Contrasting roles for CXCR2 during experimental colitis.

Ajuebor MN, Zagorski J, Kunkel SL, Strieter RM, Hogaboam CM.

Exp Mol Pathol. 2004 Feb;76(1):1-8.

PMID:
14738862
6.

The possible mechanisms of Picrasma quassiodes (D. Don) Benn. in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in mice.

Zhao W, Sun C, He J, Chen L, Zhang Y, Sun W.

J Ethnopharmacol. 2013 Jan 30;145(2):424-30. doi: 10.1016/j.jep.2012.11.001. Epub 2012 Nov 16.

PMID:
23164762
7.

Potential role for ET-2 acting through ETA receptors in experimental colitis in mice.

Claudino RF, Leite DF, Bento AF, Chichorro JG, Calixto JB, Rae GA.

Inflamm Res. 2017 Feb;66(2):141-155. doi: 10.1007/s00011-016-1001-7. Epub 2016 Oct 24.

PMID:
27778057
8.

Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.

Singer M, Trugnan G, Chelbi-Alix MK.

Innate Immun. 2011 Aug;17(4):365-74. doi: 10.1177/1753425910371668. Epub 2010 Aug 6.

PMID:
20693187
9.

Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.

Dutra RC, Cola M, Leite DF, Bento AF, Claudino RF, Nascimento AF, Leal PC, Calixto JB.

Br J Pharmacol. 2011 May;163(2):358-74. doi: 10.1111/j.1476-5381.2011.01226.x.

10.

Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome.

Brait VH, Rivera J, Broughton BR, Lee S, Drummond GR, Sobey CG.

Brain Res. 2011 Feb 4;1372:169-79. doi: 10.1016/j.brainres.2010.11.087. Epub 2010 Dec 4.

PMID:
21138735
11.

The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.

Manjavachi MN, Costa R, Quintão NL, Calixto JB.

Neuropharmacology. 2014 Apr;79:17-27. doi: 10.1016/j.neuropharm.2013.10.026. Epub 2013 Nov 1.

PMID:
24184386
12.

Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.

Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP.

Neuroimmunomodulation. 2006;13(2):114-21. Epub 2006 Oct 14.

PMID:
17077645
13.

Pharmacological inhibition of CXCR2 chemokine receptors modulates paraquat-induced intoxication in rats.

Costa KM, Maciel IS, Kist LW, Campos MM, Bogo MR.

PLoS One. 2014 Aug 25;9(8):e105740. doi: 10.1371/journal.pone.0105740. eCollection 2014.

14.

Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice.

Fukuda W, Takagi T, Katada K, Mizushima K, Okayama T, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Handa O, Konishi H, Yagi N, Ichikawa H, Yoshikawa T, Cepinskas G, Naito Y, Itoh Y.

Dig Dis Sci. 2014 Jun;59(6):1142-51. doi: 10.1007/s10620-013-3014-1. Epub 2014 Jan 19.

PMID:
24442266
15.

A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice.

Matzer SP, Zombou J, Sarau HM, Röllinghoff M, Beuscher HU.

Immunobiology. 2004;209(3):225-33.

PMID:
15518334
16.

Fatty acid synthase inhibitor C75 ameliorates experimental colitis.

Matsuo S, Yang WL, Aziz M, Kameoka S, Wang P.

Mol Med. 2014 Jan 17;20:1-9. doi: 10.2119/molmed.2013.00113.

17.

Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.

Xu J, Zheng C, Huang Y, Liang Y.

Chin Med J (Engl). 2014;127(12):2368-75.

PMID:
24931258
18.

Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.

Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, Blanchard J, Edwards MJ, Lentsch AB.

Hepatology. 2008 Oct;48(4):1213-23. doi: 10.1002/hep.22471.

19.

Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.

Keates AC, Castagliuolo I, Cruickshank WW, Qiu B, Arseneau KO, Brazer W, Kelly CP.

Gastroenterology. 2000 Oct;119(4):972-82.

PMID:
11040184
20.

Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice.

Ruyssers NE, De Winter BY, De Man JG, Loukas A, Pearson MS, Weinstock JV, Van den Bossche RM, Martinet W, Pelckmans PA, Moreels TG.

Inflamm Bowel Dis. 2009 Apr;15(4):491-500. doi: 10.1002/ibd.20787.

PMID:
19023900

Supplemental Content

Support Center